Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery

NCT00870103 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Vigadexa (moxifloxacin 0.5% and dexamethasone 0.1%) eye drops

Sponsor

Alcon Research